Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
DeepSeek is a Hangzhou-based startup whose controlling shareholder is Liang Wenfeng, cofounder of quantitative hedge fund ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
OpenAI has recently released its first AI agent, Operator. But how is it different from the ChatGPT platform? Let's find out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback